538 related articles for article (PubMed ID: 21247241)
1. Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.
Liatsikos E; Kyriazis I; Kallidonis P; Stolzenburg JU
Aging Male; 2011 Sep; 14(3):141-9. PubMed ID: 21247241
[TBL] [Abstract][Full Text] [Related]
2. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
[TBL] [Abstract][Full Text] [Related]
3. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
4. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
5. Treatment of benign prostatic hyperplasia.
Pinheiro LC; Martins Pisco J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):256-60. PubMed ID: 23244720
[TBL] [Abstract][Full Text] [Related]
6. [Benign hypertrophy of the prostate: which treatment, for whom?].
Schulman C
Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
[TBL] [Abstract][Full Text] [Related]
7. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
8. Management of Benign Prostatic Hyperplasia in Older Adults.
Woodard TJ; Manigault KR; McBurrows NN; Wray TL; Woodard LM
Consult Pharm; 2016; 31(8):412-24. PubMed ID: 27535076
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
[TBL] [Abstract][Full Text] [Related]
10. Urological disorders in men: urinary incontinence and benign prostatic hyperplasia.
Miller SW; Miller MS
J Pharm Pract; 2011 Aug; 24(4):374-85. PubMed ID: 21984774
[TBL] [Abstract][Full Text] [Related]
11. Revival of thermotherapy for benign prostatic hyperplasia.
Djavan B; Kazzazi A; Bostanci Y
Curr Opin Urol; 2012 Jan; 22(1):16-21. PubMed ID: 22080873
[TBL] [Abstract][Full Text] [Related]
12. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Silva J; Silva CM; Cruz F
Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
[TBL] [Abstract][Full Text] [Related]
14. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
Pham H; Sharma P
Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
[TBL] [Abstract][Full Text] [Related]
15. Treatment and pharmacologic management of BPH in the context of common comorbidities.
O'Leary MP
Am J Manag Care; 2006 Apr; 12(5 Suppl):S129-40. PubMed ID: 16613527
[TBL] [Abstract][Full Text] [Related]
16. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study.
Lukacs B; Cornu JN; Aout M; Tessier N; Hodée C; Haab F; Cussenot O; Merlière Y; Moysan V; Vicaut E
Eur Urol; 2013 Sep; 64(3):493-501. PubMed ID: 23465519
[TBL] [Abstract][Full Text] [Related]
17. Impact of medical therapy on transurethral resection of the prostate: two decades of change.
Izard J; Nickel JC
BJU Int; 2011 Jul; 108(1):89-93. PubMed ID: 20883490
[TBL] [Abstract][Full Text] [Related]
18. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
[TBL] [Abstract][Full Text] [Related]
19. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
